Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384407844> ?p ?o ?g. }
- W4384407844 endingPage "1253" @default.
- W4384407844 startingPage "1241" @default.
- W4384407844 abstract "In patients with psoriatic arthritis (PsA), potential differences in care by race/ethnicity have not been well studied.This retrospective, observational cohort analysis utilized the IBM MarketScan® Multi-State Medicaid database. Patients aged ≥ 18 years with two or more PsA-related claims between January 1, 2010 and December 31, 2019, and ≥ 12 months of continuous enrollment before the first diagnosis of PsA (index date) were included. Outcomes evaluated were the use of disease-modifying antirheumatic drugs (DMARDs) overall and by type (conventional synthetic, biologic, targeted synthetic) within 12 months following initial PsA diagnosis, as well as the time to DMARD initiation after initial PsA diagnosis, stratified by race/ethnicity. Multivariate Cox proportional hazards models were used to assess potential associations between patient baseline characteristics and time to DMARD initiation.Among patients with newly diagnosed PsA (N = 3432), the mean age was 44.4 years, 69.9% were female, 77.4% were White, and 10.1% were Black. Of the 2993 patients with at least 12 months of follow-up, fewer Black patients received any DMARD therapy compared with White patients (68.4 vs. 76.4%, respectively, p = 0.002), and, specifically, a lower percentage of Black patients received biologic DMARDs compared with White patients (33.6 vs. 42.6%, respectively, p = 0.003). After adjusting for baseline characteristics, Black patients had significantly longer time to initiation of any DMARD (HR [95% CI] 0.82 [0.71-0.94]) and biologic DMARD (0.84 [0.71-0.99]) compared with White patients. Other baseline variables such as older age, anxiety, and hepatitis C were also significantly associated with longer time to any DMARD initiation after initial PsA diagnosis.Time to treatment initiation was significantly longer in Black patients compared with White patients with newly diagnosed PsA. These findings suggest care delivery disparities in patients with PsA and highlight the need for future studies to understand factors that drive the observed differences in drug therapy by race/ethnicity." @default.
- W4384407844 created "2023-07-16" @default.
- W4384407844 creator A5011376025 @default.
- W4384407844 creator A5014572762 @default.
- W4384407844 creator A5016200755 @default.
- W4384407844 creator A5027761623 @default.
- W4384407844 creator A5038457578 @default.
- W4384407844 creator A5075257656 @default.
- W4384407844 date "2023-07-15" @default.
- W4384407844 modified "2023-10-17" @default.
- W4384407844 title "Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study" @default.
- W4384407844 cites W1915713161 @default.
- W4384407844 cites W1968405676 @default.
- W4384407844 cites W2004262575 @default.
- W4384407844 cites W2053054216 @default.
- W4384407844 cites W2078157933 @default.
- W4384407844 cites W2083707884 @default.
- W4384407844 cites W2130111449 @default.
- W4384407844 cites W2218980995 @default.
- W4384407844 cites W2297053275 @default.
- W4384407844 cites W2774310909 @default.
- W4384407844 cites W2884469621 @default.
- W4384407844 cites W2891745945 @default.
- W4384407844 cites W2901986848 @default.
- W4384407844 cites W2982013225 @default.
- W4384407844 cites W2985891039 @default.
- W4384407844 cites W2993100020 @default.
- W4384407844 cites W2995995265 @default.
- W4384407844 cites W3010766827 @default.
- W4384407844 cites W3044817023 @default.
- W4384407844 cites W3130834559 @default.
- W4384407844 cites W3157387179 @default.
- W4384407844 cites W3159598855 @default.
- W4384407844 cites W3191700528 @default.
- W4384407844 cites W3202507436 @default.
- W4384407844 cites W3216291628 @default.
- W4384407844 cites W4220709421 @default.
- W4384407844 cites W4229049401 @default.
- W4384407844 cites W4241915332 @default.
- W4384407844 cites W4283589104 @default.
- W4384407844 cites W4283752722 @default.
- W4384407844 cites W4293105753 @default.
- W4384407844 cites W4311292188 @default.
- W4384407844 doi "https://doi.org/10.1007/s40744-023-00580-y" @default.
- W4384407844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37453020" @default.
- W4384407844 hasPublicationYear "2023" @default.
- W4384407844 type Work @default.
- W4384407844 citedByCount "0" @default.
- W4384407844 crossrefType "journal-article" @default.
- W4384407844 hasAuthorship W4384407844A5011376025 @default.
- W4384407844 hasAuthorship W4384407844A5014572762 @default.
- W4384407844 hasAuthorship W4384407844A5016200755 @default.
- W4384407844 hasAuthorship W4384407844A5027761623 @default.
- W4384407844 hasAuthorship W4384407844A5038457578 @default.
- W4384407844 hasAuthorship W4384407844A5075257656 @default.
- W4384407844 hasBestOaLocation W43844078441 @default.
- W4384407844 hasConcept C126322002 @default.
- W4384407844 hasConcept C137403100 @default.
- W4384407844 hasConcept C144024400 @default.
- W4384407844 hasConcept C160735492 @default.
- W4384407844 hasConcept C162324750 @default.
- W4384407844 hasConcept C167135981 @default.
- W4384407844 hasConcept C19165224 @default.
- W4384407844 hasConcept C2776260265 @default.
- W4384407844 hasConcept C2776534028 @default.
- W4384407844 hasConcept C2779134260 @default.
- W4384407844 hasConcept C2908647359 @default.
- W4384407844 hasConcept C38180746 @default.
- W4384407844 hasConcept C45827449 @default.
- W4384407844 hasConcept C50382708 @default.
- W4384407844 hasConcept C50522688 @default.
- W4384407844 hasConcept C71924100 @default.
- W4384407844 hasConcept C72563966 @default.
- W4384407844 hasConcept C99454951 @default.
- W4384407844 hasConceptScore W4384407844C126322002 @default.
- W4384407844 hasConceptScore W4384407844C137403100 @default.
- W4384407844 hasConceptScore W4384407844C144024400 @default.
- W4384407844 hasConceptScore W4384407844C160735492 @default.
- W4384407844 hasConceptScore W4384407844C162324750 @default.
- W4384407844 hasConceptScore W4384407844C167135981 @default.
- W4384407844 hasConceptScore W4384407844C19165224 @default.
- W4384407844 hasConceptScore W4384407844C2776260265 @default.
- W4384407844 hasConceptScore W4384407844C2776534028 @default.
- W4384407844 hasConceptScore W4384407844C2779134260 @default.
- W4384407844 hasConceptScore W4384407844C2908647359 @default.
- W4384407844 hasConceptScore W4384407844C38180746 @default.
- W4384407844 hasConceptScore W4384407844C45827449 @default.
- W4384407844 hasConceptScore W4384407844C50382708 @default.
- W4384407844 hasConceptScore W4384407844C50522688 @default.
- W4384407844 hasConceptScore W4384407844C71924100 @default.
- W4384407844 hasConceptScore W4384407844C72563966 @default.
- W4384407844 hasConceptScore W4384407844C99454951 @default.
- W4384407844 hasFunder F4320317188 @default.
- W4384407844 hasIssue "5" @default.
- W4384407844 hasLocation W43844078441 @default.
- W4384407844 hasLocation W43844078442 @default.
- W4384407844 hasOpenAccess W4384407844 @default.
- W4384407844 hasPrimaryLocation W43844078441 @default.